Cargando…

P32.01 Clinical Screening for COVID-19 in Asymptomatic Patients With Lung Cancer: Brazilian Experience From a Single Institution

Detalles Bibliográficos
Autores principales:	Teixeira, C.H., Yen, C., Teixeira, T., Ferreira, E., Younes, R., Silva, A., Uchiyama, A., Lopes, M., Silva, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	P32 Management of Lung Cancer in the Era of Covid-19 - Screening and Diagnosis of Lung Cancer during Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523157/ http://dx.doi.org/10.1016/j.jtho.2021.08.414

Ejemplares similares

P32.02 2020 in Hindsight: Newly Diagnosed Lung Cancer Patients in the Time of COVID-19 at a Tertiary Canadian Cancer Centre
por: Petersen, L., et al.
Publicado: (2021)

P34.01 6-Weekly vs 3-Weekly Pembrolizumab – Toxicities and Tolerance in The COVID-era
por: Douglas, C., et al.
Publicado: (2021)

P31.01 Impact of COVID-19 on Lung Cancer Diagnosis and Treatment: A Retrospective Chart Review
por: Kasymjanova, G., et al.
Publicado: (2021)

P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19
por: Olson, E., et al.
Publicado: (2021)

P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic
por: Mohiuddin, M., et al.
Publicado: (2021)

P34.03 Lung Cancer Patients and COVID-19 in a District General Hospital in the UK
por: Aujayeb, A.
Publicado: (2021)

P34.06 Antiproliferative Effects of Paclitaxel on PC9-MET Cells During the Coronavirus Disease 2019 Pandemic
por: Mohiuddin, M., et al.
Publicado: (2021)

P33.01 Air Leak Due COVID-19 in a Lung Cancer Patient
por: Aujayeb, A.
Publicado: (2021)

P31.03 The Impact of the COVID-19 Pandemic on a Thoracic Tumor Unit of a Tertiary Hospital in Spain
por: Cudero, L., et al.
Publicado: (2021)

P31.06 Impact of Covid-19 Infection on Lung Cancer Patients: Experience in Latin-American Country ACHOCC-19L Study
por: Ospina Serrano, A.V., et al.
Publicado: (2021)

P31.02 Impact of COVID-19 Pandemic in Spanish and Portuguese Lung Cancer Patients
por: Araujo, A., et al.
Publicado: (2021)

Initial results of the National Lung Cancer Screening Trial
por: McLoud, T.C.
Publicado: (2011)

P31.05 SARS-CoV-2 and Lung Cancer: Pandemic Impact in Diagnosis, Staging and Management
por: Tsukazan, M.T., et al.
Publicado: (2021)

P31.04 Global Impact of COVID-19 on NSCLC Surgery: Initial Analysis of the CovidSurg-Cancer Study
por: Patel, A., et al.
Publicado: (2021)

NELSON lung cancer screening study
por: Zhao, Ying Ru, et al.
Publicado: (2011)

Lung cancer screening: rationale and background
por: Diederich, S.
Publicado: (2011)

EP06.01-014 Lung Resections After COVID: Short-term Outcomes
por: Kodaganur Gopinath, S., et al.
Publicado: (2022)

EP06.01-003 Impact of COVID-19 on Lung Cancer Patients; The Patients’ Perspective
por: Samnani, S., et al.
Publicado: (2022)

EP06.01-001 The Longitudinal Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Centre: A Retrospective Chart Review
por: Rizzolo, A., et al.
Publicado: (2022)

EP06.01-006 Multidisciplinary Team during the COVID-19 Pandemic: The BE-PACIFIC Italian Observational Study Analysis
por: Ramella, S., et al.
Publicado: (2022)

EP06.01-007 Fate of Pneumonectomy Patients During Covid-19 Pandemic
por: Güler, G., et al.
Publicado: (2022)

EP06.01-008 COVID-Protected Pathways for Image Guided Lunc Cancer Intervention During the COVID-19 Pandemic: A Cohort Study
por: Sheeka, A., et al.
Publicado: (2022)

EP06.01-017 Clinical Impact of SARS-CoV2 Pandemic in the Diagnosis of Early-Stage Thoracic Tumours
por: Garitaonaindía Díaz, Y., et al.
Publicado: (2022)

EP06.01-009 Maintaining Thoracic Services During COVID-19 - A Single Centre Experience
por: Walji, H.D., et al.
Publicado: (2022)

EP06.01-016 Nationwide Activity of Lung Cancer Surgery Before and During the COVID-19 Pandemic
por: Laisaar, T., et al.
Publicado: (2022)

EP06.01-004 Lung Cancer Resection During the Covid-19 Pandemic: A Single Centre Study
por: Oyebanji, T.N., et al.
Publicado: (2022)

EP06.01-002 Cancer Care in a Time of COVID: Lung Cancer Patient’s Experience of Telehealth and Connectedness.
por: Fraser, A.
Publicado: (2022)

Image-Guided Percutaneous and Transarterial Therapies for Primary and Metastatic Lung Cancer
por: Mansur, Arian, et al.
Publicado: (2023)

EP06.01-012 Impact of COVID-19 on the Stage of Lung Cancer Diagnosis at the Mohamed VI Center for Cancer Treatment in Morocco
por: Panandtigri, S., et al.
Publicado: (2022)

EP06.01-005 COVID-19 and Post-COVID Outcomes in Lung Cancer Patients: Experience from an Indian Cancer Center
por: Mondal, D., et al.
Publicado: (2022)

EP06.01-013 Differences of Oncology Treatment for Lung Cancer Patients in Pandemic COVID-19 Year: Our Clinical Experience
por: crvenkova, s., et al.
Publicado: (2022)

EP06.01-015 Will Virtual Care Stand the Test of Time; One Site’s Perspective on the Continuity of Virtual Care Post-Pandemic
por: Lee, S., et al.
Publicado: (2022)

EP06.01-011 COVID-19 Impact in Thoracic Surgery: a Comparison Between Public and Private Care in a Single-Center Facility
por: Casanova Schulze, P.A., et al.
Publicado: (2022)

EP06.01-010 Clinical Outcomes after Hypo Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer During The Covid-19 Pandemic In Morocco
por: cherkaoui, M., et al.
Publicado: (2022)

Cell migration leads to spatially distinct but clonally related airway cancer precursors
por: Pipinikas, Christodoulos P, et al.
Publicado: (2014)

Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC
por: Wang, Hao, et al.
Publicado: (2022)

Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study
por: Liu, Yuting, et al.
Publicado: (2022)

Predictors of Readmission After Pulmonary Resection in Patients With Lung Cancer: A Systematic Review and Meta-analysis
por: Liu, Jie, et al.
Publicado: (2022)

Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China
por: Li, Tao, et al.
Publicado: (2023)

Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
por: Chen, Wenrui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nd0oq0goccj0hfqna93m2gjtbe